Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/2008
12/04/2008WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
12/04/2008WO2008144925A1 Iap bir domain binding compounds
12/04/2008WO2008082887A3 Inhibitors of poly(adp-ribose)polymerase
12/04/2008WO2008002849A3 Aryl sulfones
12/04/2008US20080300261 Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease
12/04/2008US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997800A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008CN101316827A Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316826A Amine compound and organic electroluminescent element employing the same
12/03/2008CN101316585A Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
12/03/2008CN100439339C 2-pyridone derivatives as netrophil elastase inhibitors and their use.
12/03/2008CN100439338C Compositions, methods and kits pertaining to luminescent compounds
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008US7459551 Method for preparing cyclic compounds
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008CA2377668C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2265672C Pyrazinones and triazinones and their derivatives thereof
11/2008
11/27/2008WO2008142285A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
11/27/2008WO2008122511A3 Process for preparing 2-amino- [5-(1(s), 2-dihydroxyethyl) or - (ks) -hydroxy-2-haloethyl) ] -pyrazine derivatives by enzymatic reduction of the corresponding ketones
11/27/2008WO2008108944A3 Integrated photoactive small molecules and uses thereof
11/27/2008WO2008030838A3 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity
11/27/2008WO2007103233A3 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293944 Piperazinyl Compounds
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293742 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4
11/27/2008US20080293741 Tricyclo Substituted Amides as Glucokinase Modulators
11/27/2008US20080293730 Tricyclo Substituted Amides
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293717 Aryl sulfonamides
11/27/2008US20080293706 Quinoxaline derivatives as pi3 kinase inhibitors
11/27/2008US20080293699 Inhibitors of thapsigargin-induced cell death
11/27/2008CA2683350A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof a antibacterial medicaments
11/26/2008EP1995242A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
11/26/2008EP1994012A1 Novel tricyclic dihydropyrazines as potassium channel openers
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008CN101312955A Process for producing optically active piperazine compound
11/26/2008CN101312948A Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436418C N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
11/25/2008US7456283 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456184 Agonist or antgonist and binders and inversion of agonist
11/25/2008US7456180 Piperazine derivatives and their use as therapeutic agents
11/20/2008WO2008140197A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008139894A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
11/20/2008WO2008139235A2 Novel piperazine salts as d3/d2 antagonists
11/20/2008WO2007109362A3 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
11/20/2008WO2007034445A3 Novel piperazine derivatives as renin inhibitors for cardiovascular events and renal insufficiency
11/20/2008CA2686547A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008CA2684404A1 Novel piperazine salts as d3/d2 antagonists
11/20/2008CA2683941A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/19/2008CN101309904A 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
11/19/2008CN101307025A Chuanxiong alcohol carnitine ester compounds
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7452994 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/18/2008US7452921 for use in radiation curing; printing inks or varnishes; 4-Piperazinoacetophenone
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452891 MCH antagonists and their use in the treatment of obesity
11/18/2008CA2305802C Amide derivatives or salts thereof
11/18/2008CA2296725C Polyhydroxybutylpyrazines, their preparation and medicines containing them
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008028168A3 Serine-threonine protein kinase and parp modulators
11/13/2008US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects
11/13/2008US20080280875 Fused phenyl amido heterocyclic compounds
11/13/2008US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers
11/13/2008US20080279917 Bisbenzamidines for the Treatment of Pneumonia
11/12/2008EP1989188A1 Therapeutic piperazines as pde4 inhibitors
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/11/2008US7449467 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/11/2008US7449460 3-Quinolinecarbonitrile protein kinase inhibitors
11/06/2008US20080275238 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction; diabetes
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/05/2008EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008CN100430377C N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446210 Factor Xa compounds
11/04/2008US7446107 Soluble crystalline form of cis-itraconazole, posaconazole or saperconazole comprising the reaction product of cis-itraconazole, posaconazole or saperconazole and an organic acid or an inorganic acid; use in treating or preventing local and systemic fungal, yeast, and dermatophyte infections
10/2008
10/30/2008WO2008130151A1 Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269248 Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269231 Phenazine Compounds and Use Thereof in Autoimmune and Inflammatory Disease
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 187